(Reuters) – Johnson & Johnson on Tuesday said Chief Scientific Officer Paul Stoffels, who spearheaded the development of the company’s single-shot COVID-19 vaccine, will retire at the end of this year.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)